参考文献/References:
[1]卢俊.早期宫颈癌术后复发的相关因素分析[D].大连:大连医科大学,2016.[2]余淼,冉立,常建英,等.淋巴结转移和淋巴结阳性比率对早期宫颈癌预后的影响分析[J].中国临床医生杂志,2020,48(6):733-736.[3]王登凤,石宇,张国楠,等.393例ⅠB1-ⅡA2 期子宫颈癌患者的临床病理与预后分析[J].肿瘤预防与治疗,2017,30(4):254-260.[4]Escande A,Gouy S,Mazeron R,et al.Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: clinical results and prognostic factors[J].Gynecol Oncol,2017,144(3):541-546.[5]姜光瑶,赵志伟,吴江,等.宫颈癌术后患者临床预后影响的多因素分析[J].西部医学,2015,27(12):1806-1809.[6]Vural C,Bayrak BY,Muezz?覦noglu B,et al.Perineural invasion is a valuable prognostic factor in advanced stage and/or Node(+)cervical cancer[J].Indian J Pathol Microbiol,2017,60(1):27-32.[7]王彤,武明辉,吴玉梅,等.北京市宫颈癌17年发病率变化及趋势分析[J].北京医学,2017,39(6):599－602,651．[8]高慧莉,郭幼军.年轻宫颈癌患者的临床、病理特征及预后的影响因素分析[J].中国综合临床,2017,33(2):167-170．[9]张英,邓丽娜,徐传彬,等.35岁以下宫颈癌患者术后复发的危险因素及其分子病理特征分析[J].中国妇幼保健,2018,33(13):2896－2899．[10]吴菲远,李晶晶,刘小玲.影响宫颈锥切术治疗Ⅰa1期宫颈癌预后的相关因素分析[J]．广东医科大学学报,2017,35(4):402－404．[11]彭俊,黄勇.90例年轻宫颈癌患者临床特征及术后复发和预后相关因素分析[J].实用妇产科杂志,2016,32(1):42-45.[12]王光艳,李倩,钱露茜,等.宫颈小细胞癌26例临床病理特征及预后分析[J].肿瘤学杂志,2019,25(6):541-546.[13]孙瑞瑞.早期宫颈癌FIGO分期与手术病理分期的差异性及淋巴结转移危险因素的分析[D].乌鲁木齐:新疆医科大学,2016.[14]Lee DY,Chong C,Lee M,et al.Prognostic factors in neuroendocrine cervical carcinoma[J].Obstet Gynecol Sci,2016,59(2):116-122.[15]Ramirez PT,Frumovitz M,Pareja R,et al.Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer[J].N Engl J Med,2018,379(20):1895-1904．[16]葛阳清,侯金凤,曾敏,等.宫颈癌根治术中加行腹主动脉旁淋巴结切除在ⅠB2及ⅡA2期宫颈癌治疗中的临床分析[J].齐齐哈尔医学院学报,2017,38(1):59-61.[17]黄影蓓,李翠丽.术前血浆D-二聚体与早期宫颈癌术后复发相关性研究[J].中华肿瘤防治杂志,2017,24(8):566－569.[18]郭敏,朱波,叶琳,等.宫颈癌术后HPV持续感染的危险因素及对免疫失衡的影响[J].中华医院感染学杂志,2017,27(17):4000-4003.[19]梅洁,汪玲玲,王丹菡,等.人乳头瘤病毒多重感染与宫颈癌的临床特征[J].中华医院感染学杂志,2017,27(24):5657-5660.[20]De Brot L,Pellegrini B,Moretti ST,et al.Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix[J].Cancer Cytopathol,2017,125(2):138-143.[21]王素琴,常青,李秀荣.75例老年宫颈癌的病理分型及其预后[J].中国老年学杂志,2017,37(21):5322-5323.[22]屠晔强,唐秋,闫鼎鼎,等.同步放化疗对伴有盆腹腔淋巴结转移的宫颈癌患者疗效分析[J].中华放射肿瘤学杂志,2020,29(6):446-450.[23]李晓花,何纪恩.早期宫颈癌术后放疗预后的影响因素及生存质量分析[J].河北医药,2018,40(4):584-586.[24]Ma C,Zhang Y,Li R,et al.Risk of parametrial invasion in women with early stage cervical cancer: A meta-analysis[J].Arch Gynecol Obstet,2018,297(3):573-580.[25]莫淼,张敬,任玉兰.宫颈癌微创和开腹根治性子宫切除术比较的前瞻性、多中心、随机对照临床试验——LACC研究解读[J].中国癌症杂志,2019,29(1):63-70.[26]陈烟培,周朝娟.老年宫颈癌根治术术后复发的影响因素[J].中国老年学杂志,2020,40(1):56-59.[27]徐荣,赵红霞,张虹,等.早期宫颈癌不良预后与淋巴结比率的相关性研究[J].中国现代医学杂志,2016,23(12):77-81.[28]茅晶晶,郑孟女,胡炳真,等.不同年龄宫颈癌及癌前病变患者临床分析[J].中国临床医生杂志,2018,46(2):218-220.[29]Small W Jr,Bosch WR,Harkenrider MM,et al.NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update[J].Int J Radiat Oncol Biol Phys,2021,109(2):413-424.[30]Yoshida K,Kajiyama H,Yoshihara M,et al.Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?[J].Int J Clin Oncol,2019,24(5):567-574. [31]Rotman M,Sedlis A,Piedmonte MR,et al.A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study[J].Int J Radiat Oncol Biol Phys,2006,65(1):169-176.[32]卢淮武,陈浩,刘昀昀,等.宫颈腺癌Ⅰb期患者卵巢转移情况的临床分析[J].中华医学杂志,2016,96(3):203-206.[33]Zhu Y,Zhang G,Yang Y,et al.Perineural invasion in early-stage cervical cancer and its relevance following surgery[J].Oncol Lett,2018,15(5):6555-6561.[34]Gadducci A,Pistolesi S,Cosio S,et al.Is Perineural Invasion a Novel Prognostic Factor Useful to Tailor Adjuvant Treatment in Patients Treated With Primary Surgery for Cervical and Vulvar Carcinoma?[J].Anticancer Res,2020,40(6):3031-3037.[35]孙琴花,易蓉,杨丹.腹腔镜下宫颈癌根治术的近期疗效及患者预后的影响因素分析[J].癌症进展,2016,14(5):497-499.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(13):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(13):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(13):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[4]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(13):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[5]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(13):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[6]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(13):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[7]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(13):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[8]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(13):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[9]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(13):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[10]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(13):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]